CAT
Caterpillar Inc.
CAT has the edge over MAS overall, supported by stronger modeled upside and stronger fundamentals.
MAS
Masco Corporation
MAS offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
MAS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Healthy |
MAS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
MAS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 13x | $59.97 | -29% |
| Fair | 17x | $79.10 | -6.4% |
| Current | 18x | $84.48 | — |
| Forward | 18x | $84.48 | — |
| Expensive | 21x | $97.54 | +15% |
Historical ranges are pointers, not guarantees.
MAS has the edge over CAT in the historical PE scenario, which offers more potential upside but is not a forecast.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
CAT has the edge over MAS on the outlook, with more favorable valuation and revenue expectations.
MAS Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect MAS's earnings to grow and its profitability to improve, with its revenue holding steady.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.73 | +17% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
MAS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.58 | -1.1% |
| Q3 2026 | $4.63 | +19% |
| Q2 2026 | $4.36 | +16% |
| Q1 2026 | $4.04 | +10% |
| Q4 2025 | $3.86 | +2.7% |
| Q3 2025 | $3.90 | +3.4% |
| Q2 2025 | $3.77 | -8% |
| Q1 2025 | $3.66 | -11% |
| Q4 2024 | $3.76 | -6.5% |
MAS has the edge over CAT on earnings, with more consistent year-over-year improvement.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over MAS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over MAS on profitability, with a higher operating margin.
MAS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2B | +2.6% |
| Q2 2026 | $2B | -2.9% |
| Q1 2026 | $1.9B | +6.5% |
| Q4 2025 | $1.8B | -1.9% |
| Q3 2025 | $1.9B | -3.3% |
| Q2 2025 | $2.1B | -1.9% |
| Q1 2025 | $1.8B | -6.5% |
| Q4 2024 | $1.8B | -2.9% |
MAS's revenue fell from its 2022 peak and has held roughly level since: $2B last quarter, up 2.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +1.4 points |
| Q2 2026 | 24% | +3.5 points |
| Q1 2026 | 16% | +0.6 points |
| Q4 2025 | 14% | -2.1 points |
| Q3 2025 | 16% | -2.2 points |
| Q2 2025 | 20% | +1.1 points |
| Q1 2025 | 16% | -0.6 points |
| Q4 2024 | 16% | +2.7 points |
MAS's operating margin was 17% last quarter, up 1.4 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
MAS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $332M | -20% |
| Q2 2026 | $453M | +68% |
| Q1 2026 | -$113M | +$77M |
| Q4 2025 | $371M | +5.7% |
| Q3 2025 | $415M | +9.8% |
| Q2 2025 | $270M | -11% |
| Q1 2025 | -$190M | -$65M |
| Q4 2024 | $351M | -17% |
MAS generated $1B in free cash flow over the past year, up 23% from the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has 461M diluted shares, down 2.1% from a year ago, with $8.1B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
MAS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.5% | -3M shares |
| 1 year | -6.2% | -13M shares |
| 3 years | -13% | -30M shares |
| 5 years | -21% | -51M shares |
| Available history | -32% | -92M shares |
MAS has the edge over CAT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $260M |
| Q2 2026 | $390M |
| Q1 2026 | $202M |
| Q4 2025 | $217M |
| Q3 2025 | $123M |
| Q2 2025 | $101M |
| Q1 2025 | $130M |
| Q4 2024 | $269M |
MAS spent $1.1B buying back its own shares over the past year, up 72% from the year before.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over MAS on leverage, with a lower net debt burden relative to earnings.
MAS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.8x | Healthy |
| Q1 2026 | 1.8x | Healthy |
| Q4 2025 | 1.7x | Healthy |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.7x | Healthy |
| Q1 2025 | 1.7x | Healthy |
| Q4 2024 | 1.5x | Healthy |
MAS's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
MAS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 66.2 | Neutral |
| Stochastic | 80.3 | Overbought |
MAS's weekly RSI is 66 (neutral) and its Stochastic is 80 (overbought).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.1% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
MAS PE vs Industrials Sector
| Metric | MAS | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 24% below |
| PE % | 59 | 58 | 1 pt above |
MAS has the edge over CAT on valuation relative to its sector.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
MAS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $75.3 | 12% above |
| 20 week MA | $75.0 | 13% above |
| 50 week MA | $70.8 | 19% above |
| 100 week MA | $69.8 | 21% above |
| 200 week MA | $67.4 | 25% above |
MAS has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
MAS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $48.1 | $56.8 | +18% |
| 2021 | $56.8 | $68.0 | +20% |
| 2022 | $68.0 | $47.1 | -31% |
| 2023 | $47.1 | $67.0 | +42% |
| 2024 | $67.0 | $73.2 | +9.3% |
| 2025 | $73.2 | $64.7 | -12% |
| 2026 YTD | $64.7 | $84.5 | +30% |
MAS has the edge over CAT on returns for 2026, with the stronger performance.